Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigenJC Aguilar, Gerardo Guillén, David Silva et al.|Immunology and Cell Biology|2004Cited by 87
Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigenYadira Lobaina, José Aguilar, Daniel Palenzuela et al.|Molecular Immunology|2004Cited by 46
HCV core protein modulates the immune response against the HBV surface antigen in miceJulio Aguilar, Verena Muzio, Nelson Acosta‐Rivero et al.|Biochemical and Biophysical Research Communications|2003Cited by 10
Development of a technological framework for using virus-like particles as adjuvants in prophylactic and therapeutic vaccines: demonstration of effect in animal models and humansGerardo Guillén, Luís Herrera, Julio Aguilar et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2011Cited by 0